JosephMPalumboDO

PubMed

• 12 citations
  Post-hoc analysis of open-label extension period of study MCI186-19 in amyotrophic lateral sclerosis.
  Koji Takei, Kikumi Tsuda, Fumihiro Takahashi, Joseph Palumbo> ;Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 2017 Sep 5
• 23 citations
  Post-hoc analysis of MCI186-17, the extension study to MCI186-16, the confirmatory double-blind, parallel-group, placebo-controlled study of edaravone in amyotrophic l...
  Fumihiro Takahashi, Koji Takei, Kikumi Tsuda, Joseph Palumbo> ;Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 2017 Sep 5
• 21 citations
  Post-hoc analysis of randomised, placebo-controlled, double-blind study (MCI186-19) of edaravone (MCI-186) in amyotrophic lateral sclerosis
  Koji Takei, Fumihiro Takahashi, Shawn Liu, Kikumi Tsuda, Joseph Palumbo> ;Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 2017 Sep 5
• 46 citations
  Edaravone and its clinical development for amyotrophic lateral sclerosis.
  Koji Takei, Kazutoshi Watanabe, Satoshi Yuki, Makoto Akimoto, Takeshi Sakata, Joseph Palumbo> ;Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 2017 Sep 5
• 23 citations
  An assessment of treatment guidelines, clinical practices, demographics, and progression of disease among patients with amyotrophic lateral sclerosis in Japan, the Uni...
  Koji Takei, Kikumi Tsuda, Fumihiro Takahashi, Manabu Hirai, Joseph Palumbo> ;Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 2017 Sep 5
• 19 citations
  Pharmacokinetic profile of edaravone: a comparison between Japanese and Caucasian populations.
  Yoshinobu Nakamaru, Shuji Kinoshita, Atsuhiro Kawaguchi, Koji Takei, Joseph Palumbo, Masayuki Suzuki> ;Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 2017 Sep 5
• 26 citations
  Risk of cardiovascular morbidity with risperidone or paliperidone treatment: analysis of 64 randomized, double-blind trials.
  Srihari Gopal, David Hough, Keith Karcher, Isaac Nuamah, Joseph Palumbo, Jesse A. Berlin, Alan Baseman, Yimei Xu, Justine M. Kent> ;Journal of Clinical Psychopharmacology. 2013 Apr 1
• 24 citations
  The Alcohol Clinical Trials Initiative (ACTIVE): Purpose and Goals for Assessing Important and Salient Issues for Medications Development in Alcohol Use Disorders
  Raymond F. Anton, Raye Z. Litten, Daniel E. Falk, Joseph Palumbo, Raymond T. Bartus, Rebecca L. Robinson, Henry R. Kranzler, Thomas R. Kosten, Roger E. Meyer, Charles ...> ;Neuropsychopharmacology. 2012 Jan 1
• 61 citations
  Dosing and switching strategies for paliperidone palmitate: based on population pharmacokinetic modelling and clinical trial data.
  Mahesh N. Samtani, Srihari Gopal, Cristiana Gassmann-Mayer, Larry Alphs, Joseph Palumbo> ;CNS Drugs. 2011 Oct 1
• 9 citations
  Deltoid injections of risperidone long-acting injectable in patients with schizophrenia.
  Jorge A. Quiroz, Sarah Rusch, An Thyssen, Joseph Palumbo, Stuart Kushner> ;Innovations in Clinical Neuroscience. 2011 Jun 1
• 7 citations
  Efficacy and Safety of Paliperidone Extended Release 1.5 mg/day-A Double-blind, Placebo- and Active-Controlled, Study in the Treatment of Patients with Schizophrenia.
  Danielle Coppola, Rama Melkote, Caroline Lannie, Jaskaran Singh, Isaac Nuamah, Srihari Gopal, David Hough, Joseph Palumbo> ;Psychopharmacology Bulletin. 2011 May 15
• 19 citations
  Number needed to treat and number needed to harm with paliperidone palmitate relative to long-acting haloperidol, bromperidol, and fluphenazine decanoate for treatment...
  Srihari Gopal, Joris Berwaerts, Isaac Nuamah, Kasem Akhras, Danielle Coppola, Ella Daly, David Hough, Joseph Palumbo> ;Neuropsychiatric Disease and Treatment. 2011 Mar 8
• 35 citations
  Long-term safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: an open-label, dose-titration, 1-year study.
  Lenard A. Adler, Camille Orman, H. Lynn Starr, Steve Silber, Joseph Palumbo, Kimberly M. Cooper, Joris Berwaerts, Diane D. Harrison> ;Journal of Clinical Psychopharmacology. 2011 Feb 1
• 10 citations
  One-year open-label safety and efficacy study of paliperidone extended-release tablets in patients with schizophrenia.
  Michelle Kramer, George M. Simpson, Valentinas Maciulis, Stuart Kushner, Yanning Liu, Pilar Lim, David Hough, Joseph Palumbo, Mariëlle Eerdekens> ;CNS Spectrums. 2010 Aug 1
• 100 citations
  Risperidone Long-Acting Injectable Monotherapy in the Maintenance Treatment of Bipolar I Disorder
  Jorge A. Quiroz, Lakshmi N. Yatham, Joseph Palumbo, Keith Karcher, Stuart Kushner, Vivek Kusumakar> ;Biological Psychiatry. 2010 Jul 15
• 162 citations
  A Randomized, Placebo-Controlled Study to Assess the Efficacy and Safety of 3 Doses of Paliperidone Palmitate in Adults With Acutely Exacerbated Schizophrenia
  Gahan J. Pandina, Jean-Pierre Lindenmayer, Þ Julia Lull, Pilar Lim, Srihari Gopal, Virginie Herben, Vivek Kusumakar, Eric Yuen, Joseph Palumbo> ;Journal of Clinical Psychopharmacology. 2010 Jun 1
• 66 citations
  A randomized, placebo- and active-controlled study of paliperidone extended release for the treatment of acute manic and mixed episodes of bipolar I disorder
  Eduard Vieta, Isaac Nuamah, Pilar Lim, Eric Yuen, Joseph Palumbo, David Hough, Joris Berwaerts> ;Bipolar Disorders. 2010 May 1
• 57 citations
  Practical guidance for dosing and switching paliperidone palmitate treatment in patients with schizophrenia.
  Srihari Gopal, C Gassmann-Mayer, Joseph Palumbo, Mahesh N. Samtani, R Shiwach, Larry Alphs> ;Current Medical Research and Opinion. 2010 Jan 15
• 82 citations
  Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, do...
  Lenard A. Adler, Brenda Zimmerman, H. Lynn Starr, Steve Silber, Joseph Palumbo, Camille Orman, Thomas J. Spencer> ;Journal of Clinical Psychopharmacology. 2009 Jun 1
• 5 citations
  Comparison of treatment completion rates for olanzapine pamoate and risperidone microspheres
  Kasem Akhras, Jaskaran Singh, Srihari Gopal, J. Schadrack, Joseph Palumbo> ;International Journal of Clinical Practice. 2009 Jun 1
• 58 citations
  Efficacy and safety of oral paliperidone extended-release tablets in the treatment of acute schizophrenia: pooled data from three 52-week open-label studies
  Robin Emsley, Joris Berwaerts, Mariëlle Eerdekens, Michelle Kramer, Rosanne Lane, Pilar Lim, David Hough, Joseph Palumbo> ;International Clinical Psychopharmacology. 2008 Nov 1
• 51 citations
  A double-blind, placebo-controlled, randomized study evaluating the effect of paliperidone extended-release tablets on sleep architecture in patients with schizophrenia.
  Remy Luthringer, Luc Staner, Nadine Noel, Muriel Muzet, Cristiana Gassmann-Mayer, K Talluri, Adriaan Cleton, Mariëlle Eerdekens, Wendy P. Battisti, Joseph Palumbo> ;International Clinical Psychopharmacology. 2007 Sep 1
• 28 citations
  An open-label extension trial of risperidone monotherapy in the treatment of bipolar I disorder.
  Robert M. A. Hirschfeld, Mariëlle Eerdekens, Amir H Kalali, Carla M. Canuso, Akbar A. Khan, Keith Karcher, Joseph Palumbo> ;International Clinical Psychopharmacology. 2006 Jan 1
• 31 citations
  Regional cerebral blood flow during acute and chronic abstinence from combined cocaine-alcohol abuse.
  Thomas R. Kosten, Catherine Cheeves, Joseph Palumbo, John Seibyl, Lawrence H. Price, Scott W. Woods> ;Drug and Alcohol Dependence. 1998 May 1
• 27 citations
  Dopaminergic responsivity during cocaine abstinence: a pilot study.
  Christopher J. McDougle, Lawrence H. Price, Joseph Palumbo, Thomas R. Kosten, George R. Heninger, Herbert D. Kleber> ;Psychiatry Research. 1992 Jul 1
• Join now to see all